Advertisement
Research Article Free access | 10.1172/JCI114822
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Find articles by Kelly, R. in: JCI | PubMed | Google Scholar
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Find articles by Eid, H. in: JCI | PubMed | Google Scholar
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Find articles by Krämer, B. in: JCI | PubMed | Google Scholar
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Find articles by O'Neill, M. in: JCI | PubMed | Google Scholar
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Find articles by Liang, B. in: JCI | PubMed | Google Scholar
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Find articles by Reers, M. in: JCI | PubMed | Google Scholar
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Find articles by Smith, T. in: JCI | PubMed | Google Scholar
Published October 1, 1990 - More info
It has long been assumed that the primary influences regulating cardiac contractility are the extent of mechanical loading of muscle fibers and the activity of the autonomic nervous system. However, the vasoactive peptide endothelin, initially found in vascular endothelium, is among the most potent positively inotropic agents yet described in mammalian myocardium. In isolated adult rat ventricular cells, endothelin's action was slow in onset but very long lasting with an EC50 of 50 pM that approximates the reported KD of the peptide for its receptor in rat heart. When the calcium activity of the buffer superfusing isolated single fura-2-loaded myocytes paced at 1.5 Hz was varied from 0.1 to 0.9 mM [Ca2+]o, 100 pM endothelin increased contractile amplitude with no significant change in diastolic or systolic [Ca2+]i, thus appearing to sensitize the myofilaments to intracellular calcium. Pertussis toxin, or prior exposure to a beta-adrenergic agonist, reduced or abolished the increase in myocyte contractility induced by endothelin. This novel and potent pharmacologic action of endothelin points to the potential importance of local, paracrine factors, perhaps derived from microvascular endothelium or endocardium, in the control of the contractile function of the heart.
Images.